Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
Current Oncology Reports
|
March 28, 2023
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future
Hui Kong Gan, Bryan W Day, Rosemary Harrup, et al.
ACS Medicinal Chemistry Letters
|
April 25, 2017
Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent
Alexander Döbber, Athena F Phoa, Ramzi H Abbassi, et al.
Biomacromolecules
|
May 5, 2023
Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic
Weijing Chu, Zachary H Houston, Nicholas L Fletcher, et al.
Cancer Medicine
|
April 9, 2023
A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients
Juliana Muller Bark, Avinash V Karpe, James D Doecke, et al.
Pharmacological Research
|
June 27, 2018
Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors
Monira Hoque, Ramzi H Abbassi, Danielle Froio, et al.
Molecular Cancer Therapeutics
|
July 10, 2012
A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells
Yi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
Cancer
|
May 31, 2023
Proteome profiling of salivary small extracellular vesicles in glioblastoma patients
Juliana Müller Bark, Lucas Trevisan França de Lima, Xi Zhang, et al.
Theranostics
|
June 3, 2020
Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity
Caterina Brighi, Lee Reid, Laura A Genovesi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 27, 2013
The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma
Amanda Tivnan, Jack Zhao, Terrance G Johns, et al.
Neuro-Oncology Advances
|
July 10, 2020
MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma
Caterina Brighi, Lee Reid, Alison L White, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
Current Oncology Reports
|
March 28, 2023
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future
Hui Kong Gan, Bryan W Day, Rosemary Harrup, et al.
ACS Medicinal Chemistry Letters
|
April 25, 2017
Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent
Alexander Döbber, Athena F Phoa, Ramzi H Abbassi, et al.
Biomacromolecules
|
May 5, 2023
Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic
Weijing Chu, Zachary H Houston, Nicholas L Fletcher, et al.
Cancer Medicine
|
April 9, 2023
A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients
Juliana Muller Bark, Avinash V Karpe, James D Doecke, et al.
Pharmacological Research
|
June 27, 2018
Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors
Monira Hoque, Ramzi H Abbassi, Danielle Froio, et al.
Molecular Cancer Therapeutics
|
July 10, 2012
A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells
Yi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
Cancer
|
May 31, 2023
Proteome profiling of salivary small extracellular vesicles in glioblastoma patients
Juliana Müller Bark, Lucas Trevisan França de Lima, Xi Zhang, et al.
Theranostics
|
June 3, 2020
Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity
Caterina Brighi, Lee Reid, Laura A Genovesi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 27, 2013
The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma
Amanda Tivnan, Jack Zhao, Terrance G Johns, et al.
Neuro-Oncology Advances
|
July 10, 2020
MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma
Caterina Brighi, Lee Reid, Alison L White, et al.
Page
of 8